Overview
Cervical cancer cells represent the pathological foundation of cervical carcinoma, the fourth most common cancer in women globally. These malignant cells typically originate from the transformation zone of the cervix, where squamous and columnar epithelia meet. Persistent infection with high-risk human papillomavirus (HPV) strains causes approximately 90% of cases, leading to cellular changes that may progress through precancerous stages (CIN) to invasive cancer. The study of cervical cancer cells has advanced significantly since George Papanicolaou developed the Pap smear in the 1940s. Modern research utilizes established cell lines like HeLa (derived from Henrietta Lacks in 1951), SiHa, and CaSki for molecular studies, drug testing, and vaccine development. These cells exhibit distinct morphological and genetic characteristics that differentiate them from healthy cervical epithelium.
Key Features
Cervical cancer cells demonstrate several hallmark features of malignancy, including uncontrolled proliferation, loss of contact inhibition, and abnormal nuclear morphology. HPV-positive cells often show integration of viral DNA (particularly E6 and E7 oncogenes) that disrupts tumor suppressor pathways. Molecular analysis reveals frequent mutations in PI3K/AKT pathways and overexpression of p16INK4a protein. Histologically, squamous cell carcinoma (80-90% of cases) appears as disorganized clusters of atypical squamous cells with high nuclear-to-cytoplasmic ratios. Adenocarcinoma variants display glandular formations with mucin production. Advanced cases may show lymphatic or vascular invasion, indicating metastatic potential. Researchers classify cell lines by their HPV status, with HPV16-positive lines being most prevalent in research settings.
Application Areas
Cervical cancer cells serve as critical tools in multiple biomedical applications. In diagnostic laboratories, cytotechnologists analyze cellular morphology in Pap tests and liquid-based cytology specimens to detect precancerous changes. Pharmaceutical companies use these cells in high-throughput screening for novel chemotherapeutic agents and targeted therapies like anti-angiogenesis drugs. In academic research, cervical cancer cell lines facilitate studies on viral oncogenesis, epithelial-mesenchymal transition, and cancer immunology. They're instrumental in developing HPV vaccines and testing combination therapies. Emerging applications include personalized medicine approaches using patient-derived xenografts and 3D organoid cultures that better mimic tumor microenvironments than traditional monolayer cultures.
Precautions
Working with cervical cancer cells requires strict biosafety protocols. While most cell lines are not classified as hazardous, primary patient samples may contain bloodborne pathogens. Laboratories should follow BSL-2 practices including biological safety cabinets, proper personal protective equipment, and decontamination procedures for all waste. Researchers must authenticate cell lines regularly to prevent cross-contamination, particularly given the prevalence of HeLa cell contamination in other lines. Ethical considerations apply when working with patient-derived materials, requiring proper consent and anonymization. Cryopreservation in liquid nitrogen requires training in safe handling to prevent explosive risks during thawing procedures.
B2B Procurement Guide
When sourcing cervical cancer cell lines for research or diagnostic purposes, prioritize reputable biological resource centers like ATCC, DSMZ, or ECACC. Verify certificates of analysis including STR profiling, mycoplasma testing, and viral status documentation. Consider purchasing low-passage vials to ensure genetic stability. For diagnostic applications, clinical laboratories typically procure prepared slides or liquid-based cytology specimens from specialized pathology suppliers. Bulk purchases may qualify for institutional discounts. Some providers offer custom services including gene-edited cell lines or matched normal/cancerous pairs for comparative studies. Always confirm shipping conditions (typically dry ice for viable cells) and import regulations for biological materials.
Related Manufacturers
- 主营：大鼠白介素、小鼠脂联素、表皮生长因子、细胞因子、ELISA试剂盒、重组蛋白
- 主营：膀胱癌细胞、人胚肾细胞、前列腺癌细胞
- 主营：ATCC细胞系、原代细胞、原代永生化
- 主营：ELISA试剂盒、PCR试剂盒、生化试剂盒、U14细胞、科研试剂
- 主营：脂蛋白、蛋白酶、肉毒碱、瘤细胞、细胞株、癌细胞、子宫肌、信号素、测试盒、切蛋白、样蛋白、羧化酶、质激素、羧肽酶、坏血酸、合成酶、视网膜、同源物、骨钙素、羧激酶、白介素、加压素、纤溶酶、骨桥素、干扰素
- 主营：腺嘌呤、微量法、试剂盒、骨细胞、瘤细胞、肝细胞、癌细胞、脂蛋白、提试剂、增菌液、测试盒、光度法、纤维素、信号素、缺锌ynb、病毒探、饥饿素、外泌体、粘蛋白、蛋白酶、混合液、半乳糖、抑制剂、激活肽、蛋白质
- 主营：U14细胞、试剂盒、ELISA试剂盒
- 主营：猫血清、缓冲液、马血清、白细胞、红细胞、鸭血清、狗血清、猴血清、青霉素、兔血清、鸡血清、驴血清、猪血清、骡ab血清、大鼠血清、牛蛙血清、小鼠血清、胎牛血清、鳟鱼血清、豚鼠血清、山羊血清、胰酶溶液、仓鼠血清、小牛血清、绵羊血清
- 主营：动物红细胞、原代细胞、细胞系、培养基、Elisa试剂盒